FEATURED/ARCHIVES (16/04/24)
×
Switching from Blonanserin Oral Tablets/Powders to Transdermal Patches Alleviates Extrapyramidal Symptoms in Patients with Schizophrenia: A 52-Week Open-Label Study · November 2021
Articles
Progress in Neuro-Psychopharmacology and Biological Psychiatry
×
Exploring the Link between Cognitive Deficit, Self-Esteem, Alexithymia, and Depressive Symptom of Schizophrenia · June 2022
Articles
Brain and Behavior
×
Understanding Psychological Mechanisms Linking Social Anxiety and Paranoia: A Cross-Cultural General Population Survey in Thailand and the United Kingdom · October 2022
Articles
Psychiatry Research Communications
×
Higher Dietary Inflammation in Patients with Schizophrenia: A Case-Control Study in Korea · June 2021
Articles
Nutrients
×
Humour‐Based Interventions for People with Schizophrenia · October 2021
Articles
Cochrane Database of Systematic Reviews
×
Decision Support System for the Differentiation of Schizophrenia and Mood Disorders Using Multiple Deep Learning Models on Wearable Devices Data · November 2022
Articles
Health Informatics Journal
×
Childhood Trauma and Suicide Risk in Hospitalized Patients with Schizophrenia: The Sequential Mediating Roles of Pandemic Related Post-Traumatic Stress Symptoms, Sleep Quality, and Psychological Distress · September 2023
Articles
Frontiers in Psychiatry
×
Virtual-Reality-Based Social Cognition and Interaction Training for Patients with Schizophrenia: A Preliminary Efficacy Study · November 2022
Articles
Frontiers in Psychiatry
×
Predictors of Cognitive Changes in Patients with Schizophrenia Undergoing Electroconvulsive Therapy · May 2023
Articles
PLOS ONE
×
Effect of Probiotic Adjuvant Therapy on Improvement of Clinical Symptoms and Interleukin 6 Levels in Patients with Schizophrenia · November 2022
Articles
Psychiatry Investigation
×
The Gut–Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production · October 2023
Articles
Nutrients
×
Which Severe Mental Illnesses Most Increase the Risk of Developing Dementia? Comparing the Risk of Dementia in Patients with Schizophrenia, Major Depressive Disorder and Bipolar Disorder · August 2023
Articles
Clinical Psychopharmacology and Neuroscience
×
Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan · March 2022
Articles
Neuropsychiatric Disease and Treatment
×
The Association between Reasons for First Using Cannabis, Later Pattern of Use, and Risk of First-Episode Psychosis: the EU-GEI Case–Control Study · May 2023
Articles
Psychological Medicine
×
Aripiprazole vs. Brexpiprazole for Acute Schizophrenia: A Systematic Review and Network Meta-Analysis · January 2020
Abstracts
Psychopharmacology
×
Cortical Thickness Abnormalities at Different Stages of the Illness Course in Schizophrenia: A Systematic Review and Meta-Analysis · April 2022
Articles
JAMA Psychiatry
×
Searching for Biomarkers in Schizophrenia and Psychosis: Case-Control Study Using Capillary Electrophoresis and Liquid Chromatography Time-of-Flight Mass Spectrometry and Systematic Review for Biofluid Metabolites · December 2021
Articles
Neuropsychopharmacology Reports
×
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia · November 2021
Articles
Clinical Psychopharmacology and Neuroscience
×
Changes in Brain Structure, Function, and Network Properties in Patients with First-Episode Schizophrenia Treated with Antipsychotics · November 2021
Articles
Frontiers in Psychiatry
×
Defining Treatment Response, Remission, Relapse, and Recovery in First-Episode Psychosis: A Survey among Korean Experts · February 2020
Articles
Psychiatry Investigation